2m 2m 2m 2m 2m 2m 2m
NEUPHORIA (NEUP)
NASDAQ
$3.44-$0.04 (-1.15%)
Price as of Oct 23, 2026 4:10 PM EDT- $18.8MMarket Cap
- -14.07%1-Year Change
- BiotechnologyIndustry
NEUPHORIA (NEUP)
$3.44-$0.04 (-1.15%)
Annual
Quarterly
06/30/2026 | 06/30/2025 | 06/30/2024 | 06/30/2023 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 1.2M -92.50% | 15.6M N/A | N/A N/A | 22,047 -91.64% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 1.2M -92.50% | 15.6M N/A | 0 -100.00% | 22,047 -91.64% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | N/A N/A | -9.0M -4.38% | -9.4M -51.98% | -19.6M +22.59% | |
Depreciation and Amortization Expense | 662,955 +0.010% | 662,890 -0.02% | 662,991 -42.70% | 1.2M +4.29% | |
Total Operating Expenses | 17.6M +5.05% | 16.8M -6.23% | 17.9M N/A | N/A N/A | |
Operating Profit | -16.5M +1,357.02% | -1.1M -93.69% | -17.9M N/A | N/A N/A | |
Interest Income | 665,571 +299.75% | 166,498 -24.35% | 220,097 N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 665,571 +299.75% | 166,498 -24.35% | 220,097 N/A | 0 N/A | |
Total Nonoperating Income and Expense | 2.9M +882.49% | 291,093 -87.41% | 2.3M +268.55% | 627,558 -89.20% | |
Income before Taxes | -13.6M +1,521.85% | -837,998 -94.62% | -15.6M -51.08% | -31.8M +46.36% | |
Income Taxes | -139,173 -70.29% | -468,366 +436.38% | -87,320 -57.77% | -206,792 +7.81% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -13.5M +3,539.28% | -369,632 -97.61% | -15.5M -51.35% | -31.8M +46.36% | |
Net Income from Continuing Operations Applicable to Common | -13.6M +1,521.85% | -837,998 -94.62% | -15.6M -51.08% | -31.8M +46.36% | |
Basic EPS and Net Income | -3.06 +1,230.43% | -0.23 +2,200.00% | -0.01 -50.00% | -0.02 0.00% | |
Diluted EPS and Net Income | -3.06 +1,230.43% | -0.23 +2,200.00% | -0.01 -50.00% | -0.02 0.00% | |
Basic Weighted Average Shares | 4.4M +170.86% | 1.6M -99.91% | 1.8B +22.39% | 1.5B +8.53% | |
Diluted Weighted Average Shares | 4.4M +170.86% | 1.6M -99.91% | 1.8B +22.39% | 1.5B +8.53% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 19.9M +39.79% | 14.2M +12.71% | 12.6M -30.92% | 18.3M -45.63% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 19.9M +39.79% | 14.2M +12.71% | 12.6M -30.92% | 18.3M -45.63% | |
Total Current Assets | 21.1M +40.08% | 15.0M +14.00% | 13.2M -34.35% | 20.1M -51.94% | |
Accumulated Depreciation | N/A N/A | N/A N/A | 45,722 N/A | N/A N/A | |
Property and Plant and Equipment and Net | N/A N/A | 2,771 +38.97% | 1,994 -47.58% | 3,804 -26.45% | |
Total Long-Term Assets | N/A N/A | 2,771 +38.97% | 1,994 -99.99% | 22.9M -2.52% | |
Total Assets | 28.7M +0.42% | 28.6M +3.40% | 27.6M -35.71% | 43.0M -34.15% | |
Income Taxes Payable | 355,940 -28.11% | 495,113 -48.62% | 963,540 N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 756,581 -82.07% | 4.2M +10.23% | 3.8M -7.27% | 4.1M +23.06% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 711,880 -28.11% | 990,226 +34,211.37% | 2,886 -99.95% | 5.7M +13.59% | |
Total Liabilities | 4.1M -57.14% | 9.6M -5.63% | 10.2M +3.07% | 9.9M +17.37% | |
Retained Earnings | -191.8M +7.54% | -178.3M +0.21% | -178.0M N/A | N/A N/A | |
Total Stockholders Equity | 24.6M +29.46% | 19.0M +8.65% | 17.5M -47.24% | 33.1M -41.76% | |
Total Shares Outstanding | 5.4M +173.51% | 2.0M -99.92% | 2.4B N/A | N/A N/A | |
Cash Flow | |||||
Cash from Operating Activities | -12.4M -16,095.38% | 77,229 +100.53% | -14.7M -31.22% | -21.3M -1.89% | |
Capital Expenditures | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | N/A N/A | N/A N/A | N/A N/A | 479,528 -22.87% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 17.9M +1,072.29% | 1.5M -89.88% | 15.1M +171.89% | 5.6M -79.42% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -1,401.09% +19,319.35% | -7.21% N/A | N/A N/A | N/A N/A | |
Return on Assets | -46.95% +3,471.99% | -1.31% -97.00% | -43.85% -25.42% | -58.80% N/A | |
Return on Equity | -61.70% +2,945.83% | -2.03% -96.69% | -61.19% -13.48% | -70.72% N/A | |
Revenue Growth | -92.50% N/A | N/A N/A | N/A N/A | -91.64% N/A | |
Current Ratio | 27.85 +681.46% | 3.56 +3.42% | 3.45 -29.20% | 4.87 N/A | |
Cash Ratio | 26.26 +679.86% | 3.37 +2.25% | 3.29 -25.50% | 4.42 N/A | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow